Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
abortion reporting
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
boston
boston blog main
boston top stories
clinical trials
content blocking
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
life sciences
medical privacy
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
reproductive justice
romesh subramanian
san diego blog main
san francisco blog main
susanna high
vertex pharmaceuticals
What
ago
data
2
×
worked
2
×
abortion
access
biotechs
civil
considering
continues
court's
decision
deprived
diseases
dobbs
drug
dyne
early
eff
expected
experimental
eyes
fair
fight
fundamental
genetic
having
humans
importance
information
ipo
ipos
justice
liberties
long
meaningful
medicines
millions
muscle
organizations
overturned
Language
unset
Current search:
worked
×
photo
×
data
×
@eff.org
10 months ago
A Year Since Dobbs, The Fight For Reproductive Privacy and Information Access Continues
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
